Skip to main content

Aquestive Therapeutics, Inc. (NASDAQ: AQST) Investor Securities Class Action Lawsuit 03/05/2026

  • If you purchased a significant amount of shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June 16, 2025 and January 8, 2026, and / or if you purchased any NASDAQ: AQST shares prior to June 2025 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: May 4, 2026. NASDAQ: AQST investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 05, 2026 - An investor in shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Aquestive Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between June 16, 2025 and January 8, 2026.   Warren, NJ based Aquestiv...



You must register (for free) or login to view the entire case.